Streetbeat News

Equity Actions

IGC

IGC Pharma, Inc. (NYSE:IGC) announced a $3 million investment from Bradbury Asset Management for 8,823,529 shares at $0.34 each. The funds will support corporate purposes and advancement of IGC-AD1. The deal is subject to NYSE approval and shares are unregistered.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 7:02 pm

LAZ

Recent analyst evaluations for Lazard (NYSE:LAZ) show a mix of perspectives, with an average 12-month price target of $44.00, up 15.79% from the previous $38.00. The company's financial performance includes solid revenue growth of 14.3%, but challenges in net margin and debt management. Lazard's ROE and ROA outperform industry benchmarks, indicating strong financial management.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 7:02 pm

ALSN

Four analysts have recently updated their evaluations of Allison Transmission (NYSE:ALSN), showing a mix of bullish to bearish sentiments. The average 12-month price target has been raised to $68.75, indicating a 15.88% increase from the previous target. Analysts from Oppenheimer, Goldman Sachs, Baird, and Morgan Stanley have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Allison Transmission's financials show strong revenue growth, net margin, ROE, and ROA, but face challenges in market capitalization and debt management.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 7:00 pm

NBSE

NeuBase Therapeutics Inc (NASDAQ:NBSE) shares plummeted by 53% to $0.47 after announcing a Special Meeting of Stockholders to vote on the company's proposed liquidation and dissolution. The Board of Directors recommends approval of these proposals. The meeting is set for May 13, online, with registration required by May 12. The company does not pay dividends or have recent buyback programs. NBSE's 52-week trading range is between $0.59 and $5.40.

Portfolio Pulse from Henry Khederian

March 26, 2024 | 6:43 pm

CDLX

Cardlytics Inc (NASDAQ:CDLX) shares plummeted 34.6% to $13.24 after announcing a $150 million convertible senior notes offering. The notes, due in 2029, aim to fund the repurchase of existing notes and for general corporate purposes. The offering and potential unwind transactions could impact the market price of Cardlytics' common stock.

Portfolio Pulse from Henry Khederian

March 26, 2024 | 6:42 pm

DIS

Walt Disney Co (NYSE:DIS) is facing a proxy battle with activist investor Nelson Peltz, who criticizes the company's long-term stock performance and has nominated himself and former CFO Jay Rasulo to the board. Morgan Stanley's James Gorman, a new Disney board member, defends the company's direction, highlighting a 30% stock increase since the year's start and expressing confidence in the current management's future-focused strategy. Disney's annual shareholder meeting is set for April 3, where shareholders will vote on board nominations.

Portfolio Pulse from Adam Eckert

March 26, 2024 | 6:05 pm

CCL

NCLH

Mizuho analyst Ben Chaiken initiated coverage on Carnival Corp (NYSE:CCL) with a Buy rating and a $21 price target, citing fleet optimization and potential for explosive earnings growth. Carnival sold nearly 20% of its lower-margin fleet during the COVID shutdown, which is expected to significantly boost EBITDA/ALBD of the remaining fleet. The company's long-term earnings outlook suggests $6.8 billion in EBITDA by 2026, with a potential to generate $6 billion in FCF over the next three years. The analyst also notes a valuation discount to Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) and favorable future yield growth from new developments.

Portfolio Pulse from Shivani Kumaresan

March 26, 2024 | 5:58 pm

C

COIN

GL

GS

HOOD

MS

PYPL

SCHW

SQ

ZION

Today's whale activity in the Financials sector highlighted significant options trading across various stocks, indicating potential trading opportunities. Notable bearish sentiment was observed in call options for C, PYPL, MS, HOOD, GS, and SCHW, while bullish sentiment was seen in COIN, ZION, and GL put options. SQ's put option trade was neutral. These activities, based on the volume and open interest, suggest market participants are positioning for potential price movements in these stocks.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:35 pm

TRU

TransUnion (NYSE:TRU) has been analyzed by 11 analysts, showing a mix of bullish to indifferent sentiments. Recent ratings have shifted towards a more cautious stance, with no bullish ratings in the last 30 days. Analysts have raised their 12-month price targets for TRU, with an average target of $81.64, marking a 15.31% increase from the previous average of $70.80. The company's financial performance shows strong revenue growth and net margin, but challenges in ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:01 pm

RRR

Red Rock Resorts (NASDAQ:RRR) has been evaluated by 12 analysts over the last three months, showing a diverse range of opinions. The average 12-month price target for RRR has increased to $59.75, up 12.52% from the previous $53.10. Analysts have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Red Rock Resorts's financial performance includes a notable revenue growth of 8.75% as of December 31, 2023, a net margin of 12.17%, an ROE of 38.54%, and an ROA of 1.44%, but with a high debt-to-equity ratio of 19.75.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:00 pm